PROPYLTHIOURACIL
NDC 70752-171, PROPYLTHIOURACIL, tablet, from QUAGEN PHARMACEUTICALS LLC.
- Product NDC
- 70752-171
- Status
- Listed
- Labeler
- QUAGEN PHARMACEUTICALS LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA080154
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70752-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PROPYLTHIOURACIL50 mg/1
Pharmacologic classes
Thyroid Hormone Synthesis Inhibitor [EPC]; Thyroid Hormone Synthesis Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70752-171-10 | 70752017110 | 100 TABLET in 1 BOTTLE (70752-171-10) |
| 70752-171-11 | 70752017111 | 1000 TABLET in 1 BOTTLE (70752-171-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/84eae11a-b572-4570-b288-ac2cdd374186NADAC price for package 70752017110
GET /v1/drugs/nadac/70752017110
Use it
Look up 70752-171 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70752-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70752-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.